A new era in the science of ageing is here.
Groundbreaking research in molecular biology, epigenetics, and advanced therapies are redefining the ageing process.
No longer seen as an inevitable decline, ageing is now recognised as a modifiable process, with the potential to slow, reverse, or even prevent many age-related diseases.
This scientific revolution promises to extend both our lifespans and “healthspans,” offering new solutions to conditions such as dementia, cardiovascular disease, and more.
Leading the charge is the London Longevity Clinic, now open on Upper Wimpole Street in the heart of Harley Street’s renowned medical district.
With the latest equipment and diagnostics, including advanced imaging and genetic testing, the clinic is dedicated to applying the latest scientific advancements in longevity medicine to optimise health, combat the effects of ageing, and help patients live longer, healthier lives.
Dr. Edouard Debonneuil, a globally recognised leader in longevity medicine, is at the helm. With a PhD in cardiopulmonary ageing and health economics, Dr. Debonneuil is known for his interdisciplinary approach, combining his expertise in engineering, biology, and data science.
He co-founded the AXA Research Fund, which has contributed over €150 million to biomedical research, leading to key discoveries like autophagy’s role in longevity and the potential of spermidine—naturally found in mushrooms and natto—to extend lifespan and improve heart health. At the same time, his pioneering book Longevity Risk has reshaped how extended lifespans impact society and health systems.
“Groundbreaking studies have shown that our biological age as distinct from our chronological age, can be influenced by factors such as diet, lifestyle and the environment, as well as emerging therapies. Scientists now believe that the biological processes driving ageing may be slowed and potentially reversed, opening doors to extending the years of life lived in good health,” explains Dr. Debonneuil.
“Institutions like the Potocsnak Longevity Institute at Northwestern University are exploring the relationship between biological and chronological age, focusing on interventions to delay age-related diseases such as dementia, diabetes, and cardiovascular conditions. The research includes molecular profiling, epigenomic studies, and testing interventions such as diet, exercise, and innovative therapies to slow ageing’s pace”, adds Dr. Debonneuil.
Founder and CEO of the London Longevity Clinic, Lily Li, a graduate of the London School of Economics and Political Science (LSE) with an MBA and certified as a Patient Care Technician/Assistant and Yoga Instructor, is a fellow pioneer in longevity medicine. Lily empowers individuals to take control of their ageing process, helping them live longer, healthier lives through both personalised care and holistic strategies. Under her leadership, the London Longevity Clinic has become an innovation hub, where patients can benefit from a fusion of clinical precision and wellness practices.
She explains: “By bridging the latest science with holistic wellness and personalised care, we empower individuals to take control of their ageing process and live fuller, healthier lives. We are unlocking the potential to redefine what it means to age, offering new hope for a healthier future.”
The London Longevity Clinic builds on the success of its clinics in Richmond and Paddington and offers services and memberships for those interested in longevity, vitality, aesthetics, and sports performance.
